|
1
|
Hu J, Wang X, Ge C, Qi W, Li Z, Wang Y,
Lai W, Ji W and Xu H: TSP-1-CD47-integrin α4β1 axis drives T cell
infiltration and synovial inflammation in rheumatoid arthritis.
Front Immunol. 16:15243042025. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tong L, Qiu J, Xu Y, Lian S, Xu Y and Wu
X: Programmed cell death in rheumatoid arthritis. J Inflamm Res.
18:2377–2393. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Al-Baldawi S, Zúñiga Salazar G, Zúñiga D,
Balasubramanian S and Mehmood KT: interstitial lung disease in
rheumatoid arthritis: A review. Cureus. 16:e536322024.PubMed/NCBI
|
|
4
|
Kimbrough BA, Crowson CS, Lennon RJ, Davis
JM III, Strangfeld A and Myasoedova E: Multiple morbidities are
associated with serious infections in patients with rheumatoid
arthritis. Semin Arthritis Rheum. 65:1523862024. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qin Y, Cai ML, Jin HZ, Huang W, Zhu C,
Bozec A, Huang J and Chen Z: Age-associated B cells contribute to
the pathogenesis of rheumatoid arthritis by inducing activation of
fibroblast-like synoviocytes via TNF-α-mediated ERK1/2 and
JAK-STAT1 pathways. Ann Rheum Dis. 81:1504–1514. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takahashi S, Saegusa J, Sendo S, Okano T,
Akashi K, Irino Y and Morinobu A: Glutaminase 1 plays a key role in
the cell growth of fibroblast-like synoviocytes in rheumatoid
arthritis. Arthritis Res Ther. 19:762017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ozen G, Pedro S and Michaud K: Major
adverse cardiovascular events and mortality with opioids versus
NSAIDs initiation in patients with rheumatoid arthritis. Ann Rheum
Dis. 82:1487–1494. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou Q, Li T, Fang G, Pang Y and Wang X:
Bioactive molecules against rheumatoid arthritis by suppressing
pyroptosis. Pharmaceuticals (Basel). 16:9522023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Singh JA: Treatment guidelines in
rheumatoid arthritis. Rheum Dis Clin North Am. 48:679–689. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang A, Suzuki T, Adachi S, Yoshida E,
Sakaguchi S and Yamamoto M: Nrf2 activation improves experimental
rheumatoid arthritis. Free Radic Biol Med. 207:279–295. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng HH, Luo M, Jiang JR and Wang CX: In
rheumatoid arthritis, a review of ncRNAs related to NF-κB signaling
pathways. Curr Pharm Biotechnol. 26:319–327. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xie B, Lin F, Bao W, Zhang Y, Liu Y, Li X,
Hou W and Zeng Q: Long noncoding RNA00324 is involved in the
inflammation of rheumatoid arthritis by targeting miR-10a-5p via
the NF-κB pathway. Immun Inflamm Dis. 11:e9062023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang J, Liu J, Li J, Jing M, Zhang L, Sun
M, Wang Q, Sun H, Hou G, Wang C and Xin W: Celastrol inhibits
rheumatoid arthritis by inducing autophagy via inhibition of the
PI3K/AKT/mTOR signaling pathway. Int Immunopharmacol.
112:1092412022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Y, Jin H, Jia W, Liu Y, Wang Y, Xue
S, Liu Y and Hao H: Ermiao San attenuating rheumatoid arthritis via
PI3K/AKT/mTOR signaling activate HIF-1α induced glycolysis. J
Ethnopharmacol. 345:1196152025. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aihaiti Y, Tuerhong X, Zheng H, Cai Y,
Yang M and Xu P: Peroxiredoxin 4 regulates tumor-cell-like
characteristics of fibroblast-like synoviocytes in rheumatoid
arthritis through PI3k/Akt signaling pathway. Clin Immunol.
237:1089642022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qi W, Lin C, Fan K, Chen Z, Liu L, Feng X,
Zhang H, Shao Y, Fang H, Zhao C, et al: Hesperidin inhibits
synovial cell inflammation and macrophage polarization through
suppression of the PI3K/AKT pathway in complete Freund's
adjuvant-induced arthritis in mice. Chem Biol Interact. 306:19–28.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Q, Li H, Liu Y and Zhao M: Epigenetic
regulation of immune and inflammatory responses in rheumatoid
arthritis. Front Immunol. 13:8811912022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shah P, Siddique A, Thakkar A, Gharat S,
Godad A, Kale P and Doshi G: An update on novel therapeutic
intervention in Rheumatoid arthritis. Int Immunopharmacol.
109:1087942022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang B, Ge Y, Zhou Y, Wang J, Xie X, Li S,
Tang M, Xu L and Tian J: miR-124a inhibits the proliferation and
inflammation in rheumatoid arthritis fibroblast-like synoviocytes
via targeting PIK3/NF-κB pathway. Cell Biochem Funct. 37:208–215.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yin J, Wang J, Su W, Tang R, Qin Z, Jia X,
Ma X and Gui S: Effects of TGMXD-208, a novel PI3K inhibitor, on
Adjuvant-induced arthritic rats by suppressing PI3K/AKT signaling
pathway. Endocr Metab Immune Disord Drug Targets. 22025.doi:
10.2174/0118715303373717250509063328 (Epub ahead of print).
PubMed/NCBI
|
|
21
|
Prajapati P and Doshi G: An update on the
emerging role of Wnt/β-catenin, SYK, PI3K/AKT, and GM-CSF signaling
pathways in rheumatoid arthritis. Curr Drug Targets. 24:1298–1316.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao HF, Wang J, Jiang HR, Chen ZP and To
SS: PI3K p110β isoform synergizes with JNK in the regulation of
glioblastoma cell proliferation and migration through Akt and FAK
inhibition. J Exp Clin Cancer Res. 35:782016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin RC, Weeks KL, Gao XM, Williams RB,
Bernardo BC, Kiriazis H, Matthews VB, Woodcock EA, Bouwman RD,
Mollica JP, et al: PI3K(p110 alpha) protects against myocardial
infarction-induced heart failure: Identification of PI3K-regulated
miRNA and mRNA. Arterioscler Thromb Vasc Biol. 30:724–732. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang HW, Shin MG, Lee S, Kim JR, Park WS,
Cho KH, Meyer T and Heo WD: Cooperative activation of PI3K by Ras
and Rho family small GTPases. Mol Cell. 47:281–290. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu X, Tang YY, Liang X, Luo W, Jiang DM
and Chen J: PTEN suppresses renal cell carcinoma proliferation and
migration via inhibition of the PI3K/AKT pathway. World J Surg
Oncol. 23:422025. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zheng Y, Wei W, Wang Y, Li T, Wei Y and
Gao S: Gypenosides exert cardioprotective effects by promoting
mitophagy and activating PI3K/Akt/GSK-3β/Mcl-1 signaling. PeerJ.
12:e175382024. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo W, Yao X, Lan S, Zhang C, Li H, Chen
Z, Yu L, Liu G, Lin Y, Liu S and Chen H: Metabolomics and
integrated network pharmacology analysis reveal SNKAF decoction
suppresses cell proliferation and induced cell apoptisis in
hepatocellular carcinoma via PI3K/Akt/P53/FoxO signaling axis. Chin
Med. 17:762022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pap T, Franz JK, Hummel KM, Jeisy E, Gay R
and Gay S: Activation of synovial fibroblasts in rheumatoid
arthritis: Lack of Expression of the tumour suppressor PTEN at
sites of invasive growth and destruction. Arthritis Res. 2:59–64.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang X, Zhao JX, Sun L and Liu XY:
Expression of CXCL16/CXCR6 in fibroblast-like synoviocytes in
rheumatoid arthritis and its role in synoviocyte proliferation.
Beijing Da Xue Xue Bao Yi Xue Ban. 49:663–668. 2017.(In Chinese).
PubMed/NCBI
|
|
30
|
Ji H, Ma J, Chen L, Chen T, Zhang S, Jia
J, Yang X, Guo C, Xiao Z and Niu P: Pyrroloquinoline quinine and
LY294002 changed cell cycle and apoptosis by regulating
PI3K-AKT-GSK3β pathway in SH-SY5Y cells. Neurotox Res. 38:266–273.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tian J, Chen JW, Gao JS, Li L and Xie X:
Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human
rheumatoid arthritis fibroblast-like synoviocytes via modulation of
PI3kinase/Akt pathway. Rheumatol Int. 33:1829–1835. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Morel J, Audo R, Hahne M and Combe B:
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
induces rheumatoid arthritis synovial fibroblast proliferation
through mitogen-activated protein kinases and phosphatidylinositol
3-kinase/Akt. J Biol Chem. 280:15709–15718. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Castellano E and Downward J: RAS
interaction with PI3K: More than just another effector pathway.
Genes Cancer. 2:261–274. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Deng C, Sun S, Zhang H, Liu S, Xu X, Hu Y,
Ma H and Xin P: Sappanone A attenuates rheumatoid arthritis via
inhibiting PI3K/AKT/NF-κB and JAK2/STAT3 signaling pathways in vivo
and in vitro. Int Immunopharmacol. 143:1135602024. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yao Y, Wang J, Zhang H, Peng T, Sun Y,
Zhang R, Meng X, Lu X, Gao Y, Jin Y, et al: Ammopiptanthus nanus
(M. Pop.) Cheng f. stem ethanolic extract ameliorates rheumatoid
arthritis by inhibiting PI3K/AKT/NF-κB pathway-mediated macrophage
infiltration. J Ethnopharmacol. 338:1189742025. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang H, Liu C, Lin X, Li X, Zeng S, Gong
Z, Xu Q, Li D and Li N: Wogonin inhibits the migration and invasion
of fibroblast-like synoviocytes by targeting PI3K/AKT/NF-κB pathway
in rheumatoid arthritis. Arch Biochem Biophys. 755:1099652024.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jia Q, Cheng W, Yue Y, Hu Y, Zhang J, Pan
X, Xu Z and Zhang P: Cucurbitacin E inhibits TNF-α-induced
inflammatory cytokine production in human synoviocyte MH7A cells
via suppression of PI3K/Akt/NF-κB pathways. Int Immunopharmacol.
29:884–890. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu Z, Zhan W, Wu L, Yu L, Xie X, Yu F,
Kong W, Bi S, Liu S, Yin G and Zhou J: The roles of forkhead box
O3a (FOXO3a) in bone and cartilage Diseases-A narrative review.
Drug Des Devel Ther. 19:1357–1375. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Audo R, Calmon-Hamaty F, Combe B, Hahne M
and Morel J: Dual effects of soluble FasL and membrane bound FasL
on fibroblast-like synoviocytes cells from rheumatoid arthritis
patients. Ann Rheum Dis. 71 (Suppl 1):A862012. View Article : Google Scholar
|
|
40
|
Mi W, Ye Q, Liu S and She QB: AKT
inhibition overcomes rapamycin resistance by enhancing the
repressive function of PRAS40 on mTORC1/4E-BP1 axis. Oncotarget.
6:13962–13977. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Choi SH, Martinez TF, Kim S, Donaldson C,
Shokhirev MN, Saghatelian A and Jones KA: CDK12 phosphorylates
4E-BP1 to enable mTORC1-dependent translation and mitotic genome
stability. Genes Dev. 33:418–435. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang S, Hu X, Su Q, Zhang H, Cheng T,
Wang J, Pei R, Li X, Zhang R, Shao H, et al: Rapamycin suppresses
rheumatoid arthritis fibroblast synovial cell proliferation and
induces apoptosis via the AKT/mTORC1 pathway. Rheumatol Autoimmun.
4:156–164. 2024. View Article : Google Scholar
|
|
43
|
Tang J, Qing MF, Li M and Gao Z:
Dexamethasone inhibits BMP7-induced osteogenic differentiation in
rat dental follicle cells via the PI3K/AKT/GSK-3β/β-catenin
pathway. Int J Med Sci. 17:2663–2672. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wu J, Cang S, Liu C, Ochiai W and Chiao
JW: Development of human prostate cancer stem cells involves
epigenomic alteration and PI3K/AKT pathway activation. Exp Hematol
Oncol. 9:122020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang J, Zhang W, Zou H, Lin Y, Lin K, Zhou
Z, Qiang J, Lin J, Chuka CM, Ge R, et al: 10-Hydroxy-2-decenoic
acid inhibiting the proliferation of fibroblast-like synoviocytes
by PI3K-AKT pathway. Int Immunopharmacol. 28:97–104. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu S, Wang J, Li J and Li F: microRNA-21
aggravates Lipopolysaccharide-induced inflammation in MH7A cells
through targeting SNF5. Inflammation. 43:441–454. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gong Z, Wang Y and Gai Y: Effects of
MiR-21 on proliferation and apoptosis of fibroblast-like
synoviocytes in rheumatoid arthritis through PTEN/PI3K/AKT
signaling pathway. Panminerva Med. Oct 24;doi:
10.23736/S0031-0808.19.03713-3 (Epub ahead of print).
|
|
48
|
Liang Y, Li H, Gong X and Ding C: Long
Non-coding RNA THRIL mediates cell growth and inflammatory response
of Fibroblast-Like synoviocytes by activating PI3K/AKT signals in
rheumatoid arthritis. Inflammation. 43:1044–1053. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xu J, Xia Y, Zhang H, Guo H, Feng K and
Zhang C: Overexpression of long non-coding RNA H19 promotes
invasion and autophagy via the PI3K/AKT/mTOR pathways in
trophoblast cells. Biomed Pharmacother. 101:691–697. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Xu H, Ding Y and Yang X: Overexpression of
long noncoding RNA H19 Downregulates miR-140-5p and activates
PI3K/AKT signaling pathway to promote invasion, migration and
Epithelial-Mesenchymal transition of ovarian cancer cells. Biomed
Res Int. 2021:66197302021. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang J, Cheng M, Gu B, Wang J, Yan S and
Xu D: CircRNA_09505 aggravates inflammation and joint damage in
collagen-induced arthritis mice via miR-6089/AKT1/NF-κB axis. Cell
Death Dis. 11:8332020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Li N, Li X, Deng L, Yang H, Gong Z, Wang
Q, Pan D, Zeng S and Chen J: 6-Shogaol inhibits the proliferation,
apoptosis, and migration of rheumatoid arthritis fibroblast-like
synoviocytes via the PI3K/AKT/NF-κB pathway. Phytomedicine.
109:1545622023. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhou M, Tan W, Hasimu H, Liu J, Gu Z and
Zhao J: Euphorbium total triterpenes improve Freund's complete
adjuvant-induced arthritis through PI3K/AKT/Bax and NF-κB/NLRP3
signaling pathways. J Ethnopharmacol. 306:1161462023. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lin W, Liu Y, Zhang S, Xu S, Qiu Q, Wang
C, Liu D, Shen C, Xu M, Shi M, et al: Schisandrin treatment
suppresses the proliferation, migration, invasion, and inflammatory
responses of fibroblast-like synoviocytes from rheumatoid arthritis
patients and attenuates synovial inflammation and joint destruction
in CIA mice. Int Immunopharmacol. 122:1105022023. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Malemud CJ: Intracellular signaling
pathways in rheumatoid arthritis. J Clin Cell Immunol. 4:1602013.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Liu S, Ma H, Zhang H, Deng C and Xin P:
Recent advances on signaling pathways and their inhibitors in
rheumatoid arthritis. Clin Immunol. 230:1087932021. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Jia ZH, Jia Y, Guo FJ, Chen J, Zhang XW
and Cui MH: Phosphorylation of STAT3 at Tyr705 regulates MMP-9
production in epithelial ovarian cancer. PLoS One. 12:e01836222017.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chen X, Han K, Lin G, Liu C, Wang S, Shi
X, Hu Z, Wu C, Xu X and Hu C: Ctenopharyngodon Idella STAT3
alleviates autophagy by up-regulating BCL-2 expression. Fish
Shellfish Immunol. 91:194–201. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Guvenir Celik E and Eroglu O: Combined
treatment with ruxolitinib and MK-2206 inhibits the JAK2/STAT5 and
PI3K/AKT pathways via apoptosis in MDA-MB-231 breast cancer cell
line. Mol Biol Rep. 50:319–329. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Malemud CJ and Blumenthal DE: Protein
kinase small molecule inhibitors for rheumatoid arthritis:
Medicinal chemistry/clinical perspectives. World J Orthop.
5:496–503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Pan J, Chang Q, Wang X, Son Y, Zhang Z,
Chen G, Luo J, Bi Y, Chen F and Shi X: Reactive oxygen
species-activated Akt/ASK1/p38 signaling pathway in nickel
compound-induced apoptosis in BEAS 2B cells. Chem Res Toxicol.
23:568–577. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yuan ZQ, Feldman RI, Sussman GE, Coppola
D, Nicosia SV and Cheng JQ: AKT2 inhibition of cisplatin-induced
JNK/p38 and Bax activation by phosphorylation of ASK1: Implication
of AKT2 in chemoresistance. J Biol Chem. 278:23432–23440. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wang L, Iorio C, Yan K, Yang H, Takeshita
S, Kang S, Neel BG and Yang W: A ERK/RSK-mediated negative feedback
loop regulates M-CSF-evoked PI3K/AKT activation in macrophages.
FASEB J. 32:875–887. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Larrea MD, Hong F, Wander SA, da Silva TG,
Helfman D, Lannigan D, Smith JA and Slingerland JM: RSK1 drives
p27Kip1 phosphorylation at T198 to promote RhoA inhibition and
increase cell motility. Proc Natl Acad Sci USA. 106:9268–9273.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Zack SR, Alzoubi O, Satoeya N, Singh KP,
Deen S, Nijim W, Lewis MJ, Pitzalis C, Sweiss N, Ivashkiv LB and
Shahrara S: Another Notch in the belt of rheumatoid arthritis.
Arthritis Rheumatol. 76:1475–1487. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Ibrahim SSA and Huttunen KM: Orchestrated
modulation of rheumatoid arthritis via crosstalking intracellular
signaling pathways. Inflammopharmacology. 29:965–974. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Boccalini G, Sassoli C, Bani D and Nistri
S: Relaxin induces up-regulation of ADAM10 metalloprotease in
RXFP1-expressing cells by PI3K/AKT signaling. Mol Cell Endocrinol.
472:80–86. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Park JS, Kim SH, Kim K, Jin CH, Choi KY,
Jang J, Choi Y, Gwon AR, Baik SH, Yun UJ, et al: Inhibition of
notch signalling ameliorates experimental inflammatory arthritis.
Ann Rheum Dis. 74:267–274. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Xu P, Xu Y, Hu B, Wang J, Pan R, Murugan
M, Wu LJ and Tang Y: Extracellular ATP enhances radiation-induced
brain injury through microglial activation and paracrine signaling
via P2X7 receptor. Brain Behav Immun. 50:87–100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zhang WJ, Luo C, Huang C, Pu FQ, Zhu JF
and Zhu ZM: PI3K/Akt/GSK-3β signal pathway is involved in P2X7
receptor-induced proliferation and EMT of colorectal cancer cells.
Eur J Pharmacol. 899:1740412021. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Cai L, Zhang K, Gao J, Xiao B, Li M, Meng
X, Chen Z, Chen X, Chen S and Li J: ACPA-induced ATP release and K+
efflux trigger NLRP3 inflammasome activation in rheumatoid
arthritis. Cell Commun Signal. 23:3022025. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Bobkova T, Bobkov A and Li Y:
Pharmacological Inhibition of the PI3K/AKT/mTOR pathway in
rheumatoid arthritis synoviocytes: A systematic review and
Meta-analysis (Preclinical). Pharmaceuticals (Basel). 18:11522025.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zhong R, Xia T, Wang Y, Ding Z, Li W, Chen
Y, Peng M, Li C, Zhang H and Shu Z: Physalin B ameliorates
inflammatory responses in lipopolysaccharide-induced acute lung
injury mice by inhibiting NF-κB and NLRP3 via the activation of the
PI3K/Akt pathway. J Ethnopharmacol. 284:1147772022. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Gong Y, Qiu J, Jiang T, Li Z, Zhang W,
Zheng X, He Z, Chen W, Wang Z, Feng X, et al: Maltol ameliorates
intervertebral disc degeneration through inhibiting PI3K/AKT/NF-κB
pathway and regulating NLRP3 inflammasome-mediated pyroptosis.
Inflammopharmacology. 31:369–384. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Hong R, Wang Y, Dong H and Geng R:
DTX3L/ARTD9 contributes to inflammation of fibroblast-like
synoviocytes by increasing STAT1 translocation. Tissue Cell.
64:1013392020. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Dinesh P and Rasool M: Berberine inhibits
IL-21/IL-21R mediated inflammatory proliferation of fibroblast-like
synoviocytes through the attenuation of PI3K/Akt signaling pathway
and ameliorates IL-21 mediated osteoclastogenesis. Cytokine.
106:54–66. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Fang L, Guo X and Pan Y: AB0116 Expression
of rictor in rheumatoid arthritis fibroblast-like synoviocytes. Ann
Rheum Dis. 72 (Suppl 3):A821.1-A821. 2014.
|
|
78
|
Herter S, Palazzo A, Bacac M, Grosmaire L,
Frey C, Pflanz S, Liu J, Tannheimer S, Umana P, Klein C, et al: The
PI3K delta selective inhibitor idelalisib minimally interferes with
immune effector function and B cell depletion mediated by
obinutuzumab (GA101) and rituximab. Blood. 124:33422014. View Article : Google Scholar
|
|
79
|
Nabergoj S, Markovič T, Avsec D, Gobec M,
Podgornik H, Jakopin Ž and Mlinarič-Raščan I: EP4 receptor agonist
L-902688 augments cytotoxic activities of ibrutinib, idelalisib,
and venetoclax against chronic lymphocytic leukemia cells. Biochem
Pharmacol. 183:1143522021. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Bhingarkar A, Wang Y, Hoshitsuki K,
Eichinger KM, Rathod S, Zhu Y, Lyu H, McNutt AT, Moreland LW,
McDermott L, et al: Duvelisib is a novel NFAT inhibitor that
mitigates adalimumab-induced immunogenicity. Front Pharmacol.
15:13979952025. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Yoon KH: Proliferation signal inhibitors
for the treatment of refractory autoimmune rheumatic diseases: A
new therapeutic option. Ann N Y Acad Sci. 1173:752–756. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Soltani A, Bahreyni A, Boroumand N, Roshan
MK, Khazaei M, Ryzhikov M, Soleimanpour S, Avan A and Hassanian SM:
Therapeutic potency of mTOR signaling pharmacological inhibitors in
the treatment of proinflammatory diseases, current status, and
perspectives. J Cell Physiol. 233:4783–4790. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Zhang F, Cheng T and Zhang SX: Mechanistic
target of rapamycin (mTOR): A potential new therapeutic target for
rheumatoid arthritis. Arthritis Res Ther. 25:1872023. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Ge Y, Yang B, Xu S, Xie X, Li F and Tian
J: Effect of miR-124a on collagen-induced arthritis in mice and the
underlying mechanisms. Zhong Nan Da Xue Xue Bao Yi Xue Ban.
47:453–461. 2022.(In English, Chinese). PubMed/NCBI
|
|
85
|
Haroon MM, Hegazy GA, Hassanien MA, Shaker
OG, Labib S and Hussein WH: Expression of lncRNA NEAT1, miR-21, and
IL17 in rheumatoid arthritis patients. Biologics. 19:201–211.
2025.PubMed/NCBI
|
|
86
|
Wu S, Wang J, Li J and Li F: microRNA-21
aggravates lipopolysaccharide-induced inflammation in MH7A cells
through targeting SNF5. Inflammation. 43:441–454. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Qu Y, Wu J, Deng JX, Zhang YP, Liang WY,
Jiang ZL, Yu QH and Li J: MicroRNA-126 affects rheumatoid arthritis
synovial fibroblast proliferation and apoptosis by targeting PIK3R2
and regulating PI3K-AKT signal pathway. Oncotarget. 7:74217–74226.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Zhu X, Zhu Y, Ding C, Zhang W, Guan H, Li
C, Lin X, Zhang Y, Huang C, Zhang L, et al: LncRNA H19 regulates
macrophage polarization and promotes Freund's complete
adjuvant-induced arthritis by upregulating KDM6A. Int
Immunopharmacol. 93:1074022021. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Wang F and Liu J: Regulating the lncRNA
DSCR9/RPLP2/PI3K/AKT axis: An important mechanism of Xinfeng
capsules in improving rheumatoid arthritis. Front Immunol.
15:14654422024. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Liu F, Wang Y, Huang D and Sun Y: LncRNA
HOTAIR regulates the PI3K/AKT pathway via the miR-126-3p/PIK3R2
axis to participate in synovial angiogenesis in rheumatoid
arthritis. Immun Inflamm Dis. 11:e10642023. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Chen Y, Du Q and Xi M: Explor N Ther
Approaches Rheum Arthritis Based Basic Signal. Pathw HSET.
54:150–156. 2023. View Article : Google Scholar
|
|
92
|
Bahekar R, Dave B, Soman S, Patel D,
Chopade R, Funde R, Kumar J, Sachchidanand S, Giri P, Chatterjee A,
et al: Discovery of 1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-ones
based novel, potent and PI3Kδ selective inhibitors. Bioorg Med Chem
Lett. 29:1313–1319. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Xu Z, Shang W, Zhao Z, Zhang B, Liu C and
Cai H: Curcumin alleviates rheumatoid arthritis progression through
the phosphatidylinositol 3-kinase/protein kinase B pathway: An in
vitro and in vivo study. Bioengineered. 13:12899–12911. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Lang F, Li Y, Yao R and Jiang M:
Osteopontin in chronic inflammatory diseases: Mechanisms, biomarker
Potential, and therapeutic strategies. Biology (Basel).
14:4282025.PubMed/NCBI
|
|
95
|
Feng YY, Wang Z and Pang H: Role of
metformin in inflammation. Mol Biol Rep. 50:789–798. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Chen K, Lin ZW, He SM, Wang CQ, Yang JC,
Lu Y, Xie XB and Li Q: Metformin inhibits the proliferation of
rheumatoid arthritis fibroblast-like synoviocytes through
IGF-IR/PI3K/AKT/m-TOR pathway. Biomed Pharmacother. 115:1088752019.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Wan L, Liu J, Huang C, Wang K, Zhu Z and
Li F: A novel pharmaceutical preparation of Tripterygium wilfordii
Hook. f. regulates macrophage polarization to alleviate
inflammation in rheumatoid arthritis. J Pharm Pharmacol.
75:1442–1457. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Cheung YM, McDonnell M and Hamnvik OR: A
targeted approach to phosphoinositide-3-kinase/Akt/mammalian target
of rapamycin-induced hyperglycemia. J Clin Endocrinol Metab.
107:e4261–e4270. 2022.PubMed/NCBI
|
|
99
|
Hanlon A and Brander DM: Managing
toxicities of phosphatidylinositol-3-kinase (PI3K) inhibitors.
Hematology Am Soc Hematol Educ Program. 2020:346–356. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Flinn IW, Miller CB, Ardeshna KM,
Tetreault S, Assouline SE, Mayer J, Merli M, Lunin SD, Pettitt AR,
Nagy Z, et al: DYNAMO: A phase II study of duvelisib (IPI-145) in
patients with refractory indolent non-Hodgkin lymphoma. J Clin
Oncol. 37:912–922. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Karaman MW, Herrgard S, Treiber DK,
Gallant P, Atteridge CE, Campbell BT, Chan KW, Ciceri P, Davis MI,
Edeen PT, et al: A quantitative analysis of kinase inhibitor
selectivity. Nat Biotechnol. 26:127–132. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Kumari A, Kaur A and Aggarwal G: The
emerging potential of siRNA nanotherapeutics in treatment of
arthritis. Asian J Pharm Sci. 18:1008452023.PubMed/NCBI
|
|
103
|
Lee ES, Ko H, Kim CH, Kim HC, Choi SK,
Jeong SW, Lee SG, Lee SJ, Na HK, Park JH and Shin JM:
Disease-microenvironment modulation by bare- or engineered-exosome
for rheumatoid arthritis treatment. Biomater Res. 27:812023.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Jiang S, Li H, Zhang L, Mu W, Zhang Y,
Chen T, Wu J, Tang H, Zheng S, Liu Y, et al: Generic Diagramming
Platform (GDP): A comprehensive database of high-quality biomedical
graphics. Nucleic Acids Res. 53:D1670–D1676. 2025. View Article : Google Scholar : PubMed/NCBI
|
